UNIVAR CORP
10-Q, 1994-06-28
CHEMICALS & ALLIED PRODUCTS
Previous: UNIVAR CORP, DEFA14A, 1994-06-28
Next: VULCAN MATERIALS CO, 10-K/A, 1994-06-28






                          UNITED STATES
                 SECURITIES & EXCHANGE COMMISSION
                      WASHINGTON, D.C. 20549


                            FORM 10-Q


            [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
              OF THE SECURITIES EXCHANGE ACT OF 1934


           For the Quarterly Period Ended May 31, 1994

                                OR

           [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
              OF THE SECURITIES EXCHANGE ACT OF 1934

                  Commission File Number 1-5858


                        UNIVAR CORPORATION


                   A Delaware            I.R.S. Employer
                   Corporation          No.  91-0816142


                       6100 Carillon Point
                   Kirkland, Washington  98033
                   Telephone No. (206) 889-3400


Indicate  by  a  check mark whether the Registrant (1) has  filed  all
reports  required to be filed by Section 13 or 15(d) of the Securities
Exchange  Act  of  1934 during the preceding 12 months  (or  for  such
shorter period that the Registrant was required to file such reports),
and  (2) has been subject to such filing requirements for the past  90
days.  YES   X   NO ____

On  June  20,  1994  the  Registrant had outstanding  21,643,288  shares
(excluding  treasury  shares) of common stock of $0.33-1/3   par  value,
which is the Registrant's only class of common stock.



UNIVAR CORPORATION and Subsidiaries

INDEX TO FORM 10-Q


                                                     PAGE NO.

PART I - FINANCIAL INFORMATION

     Item 1.   Financial Statements

           Condensed Consolidated Balance Sheets
           May 31, 1994 and February 28, 1994              3

           Consolidated Statements of Operations
           Three Months Ended May 31, 1994 and 1993        4

           Condensed Consolidated Statements of Cash Flows
           Three Months Ended May 31, 1994 and 1993        5

           Notes to Condensed Consolidated
           Financial Statements                            6


     Item 2.   Management's Discussion and Analysis of
               Financial Condition and Results
               of Operations                               7



PART II - OTHER INFORMATION

     Item 6.   Exhibits and Reports on Form 8-K            9

     

SIGNATURES                                                10



UNIVAR CORPORATION and Subsidiaries
Condensed Consolidated Balance Sheets (Unaudited) (See Notes)

(000's)                               May 31, 1994  February 28, 1994

                                               
 Assets                                        
 Current Assets:                               
   Cash and cash equivalents           $21,096          $15,530
   Receivables - net                   276,264          226,600
   Inventories                         136,694          125,638
   Other current assets                 10,769            9,486
                                       -------          -------
       Total current assets            444,823          377,254
                                                               
 Real Properties Held for                                      
 Sale and Long Term
   Receivables                          29,268           29,590
 Property, Plant and                   216,285          217,201
 Equipment - net
 Other Assets                           27,797           28,649
                                      --------        ---------
                                      $718,173        $ 652,694
                                      ========        =========
 
 
 Liabilities and                                               
 Shareholders' Equity
 Current Liabilities:                                          
   Bank overdrafts                   $  17,964        $  22,666
   Notes payable                        30,249           23,331
   Current portion of long-                         
     term debt                           7,230            7,296
   Accounts payable                    254,365          201,857
   Accrued liabilities                  37,254           38,559
                                      --------        ---------
       Total current                   347,062          293,709
         liabilities
                                                               
 Long-term Debt                        120,357          147,058
                                                               
 Other Long-term Liabilities            54,510           53,136
                                                               
 Minority Interest                       1,636            1,385
                                                               
 Shareholders' Equity                                          
   Common stock                          8,005            7,339
   Additional paid-in capital          106,616           69,798
   Retained earnings                    97,083           97,060
   Cumulative translation
     adjustment                         -7,250           -6,961
   Treasury stock                       -9,664           -9,610
   Deferred stock                                          
     compensation expense                 -182             -220
                                       -------          -------
       Total shareholders'             194,608          157,406
          equity                       -------          -------
                                      $718,173         $652,694
                                      ========         ========

UNIVAR CORPORATION and Subsidiaries
Consolidated Statements of Operations (Unaudited) (See Notes)


                                         Three Months Ended
                                              May 31,
 (000's except per share data)          1994              1993

Sales                                $503,335         $487,951
                                                              
Cost of Sales                         432,075          417,552
                                     --------         --------
Gross Margin                           71,260           70,399
                                                              
Gross Margin Percentage                 14.2%            14.4%
                                                              
Operating Expenses                     61,052           61,980
Reengineering Costs                     3,467                 
                                                             -
                                      -------          -------
Income from Operations                  6,741            8,419
                                                              
Other Income (Expense):                                       
   Interest expense                    -2,941           -3,519
   Other income-net                        50              290
                                      -------          -------
Income Before Provision for                                   
  Taxes and Minority
  Interest                              3,850            5,190
                                                              
Provision for Taxes on                             
  Income                                1,968            1,721
                                       -------          -------
                    
Income before Minority                              
Interest                                1,882            3,469
                                       ------           ------      
Minority Interest in Univar                        
Europe                                    385              196
                                     --------         --------
Net Income                           $  1,497         $  3,273
                                     ========         ========
Net Income per Share                 $   0.08         $   0.17
                                     ========         ========
                                              
Dividends per Share                  $  0.075         $  0.075
                                     ========         ========

Weighted Average Number of                       
Shares Outstanding                     20,060           19,668
                                     ========          =======

UNIVAR CORPORATION and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Unaudited) (See Notes)

                                            Three Months Ended
                                                 May 31,
(000's)                                    1994            1993

Cash Flows Provided (Used) by                   
Operating Activities:
   Net Income                           $1,497           $3,273
                                                               
   Adjustments to reconcile                                    
   net income to net cash
   provided by operating activities:
      Depreciation and                               
        amortization                     6,870            6,793
      Other                              1,525              653
   Changes in assets and                                       
   liabilities:
      Accounts receivable              -50,663          -26,158
      Inventories                      -11,024          -13,230
      Accounts payable                  49,301           31,297
      Other current assets                 287            7,619
      Other current                       
        liabilities                       -166           12,430
                                       -------          -------
Net Cash Provided (Used) by             
Operating Activities                    -2,373           22,677
                                       -------          -------
Cash Flows Used by Investing                                   
Activities:
   Investment activity                     321              201
   Additions to property,               
     plant, and equipment               -4,243           -2,575
   Changes in other assets                  98             -220
                                       -------          -------
Net Cash Used by Investing                         
Activities                              -3,824           -2,594
                                       -------          -------
Cash Flows Provided (Used) by                                  
Financing Activities:
   Short-term borrowing                  5,200          -12,832
   Common stock activity                37,432              185
   Long-term debt incurred                 393           10,000
   Reduction in long-term                        
     debt                              -28,440          -23,907
   Payment of dividends                 -2,947           -1,472
                                       -------          -------
Net Cash Provided (Used) by             
Financing Activities                    11,638          -28,026
                                       -------          -------
Effect of exchange rate                    
changes on cash                            125             -184
                                       -------          -------
Net Cash Provided (Used)                 5,566           -8,127
                                                               
Cash and Cash Equivalents at                             
Beginning of Period                     15,530           29,516
                                       -------          -------
Cash and Cash Equivalents at           
End of Period                          $21,096         $ 21,839
                                       =======         ========



UNIVAR CORPORATION and Subsidiaries
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

1.   Basis of presentation

     The   accompanying   unaudited  condensed  consolidated   financial
     statements  were  prepared in accordance  with  generally  accepted
     accounting principles for interim financial information pursuant to
     the rules and regulations of the Securities and Exchange Commission
     and  instructions to Form 10-Q.  While these statements reflect all
     adjustments (which consist of normal recurring accruals) which are,
     in  the opinion of management, necessary to a fair presentation  of
     the  results for the interim periods presented, they do not include
     all  of  the  information  and disclosures  required  by  generally
     accepted  accounting principles for complete financial  statements.
     These  statements should be read in conjunction with the  financial
     statements and notes thereto included in the Annual Report  of  the
     Registrant for the fiscal year ended February 28, 1994,  and  filed
     as Item 8 to Form 10-K, Commission File No. 1-5858.

     Results  of  operations  for interim periods  are  not  necessarily
     indicative of the results that may be expected for the year  ending
     February 28, 1995.

     2.   LIFO inventory

     The  LIFO  method of pricing is used for approximately 66%  of  the
     Registrant's  inventory. Because an actual valuation  of  inventory
     under  the  LIFO method can be made only at the end of each  fiscal
     year  based on the inventory levels and costs at that time, interim
     financial results are based on estimated LIFO adjustments  and  are
     subject to final fiscal year-end LIFO inventory amounts.

     3.   Accounting changes

     The  Corporation  adopted SFAS No. 112 "Employers'  Accounting  for
     Postemployment  Benefits" effective March 1, 1994.   Postemployment
     benefits   are  all  types  of  benefits,  other  than   retirement
     benefits,   provided  to  former  or  inactive   employees,   their
     beneficiaries,  and  covered dependents.  These  benefits  include,
     but   are   not   limited  to,  salary  continuation,  supplemental
     unemployment  benefits,  severance  benefits,  disability   related
     benefits  (including  workers'  compensation),  job  training   and
     counseling,  and  continuation  of benefits  such  as  health  care
     benefits  and  life insurance coverage.  Under this statement,  the
     costs  of postemployment benefits will be recognized on an  accrual
     basis.   The financial impact of adoption of  SFAS No. 112 was  not
     material for the first quarter.


Item  2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
             AND RESULTS OF OPERATIONS


Results of Operations

Net  earnings  for  the first fiscal quarter were $1.5 million  compared
with $3.3 million for the first quarter last fiscal year.  Sales for the
quarter  totaled $503.3 million, up 3.2% compared with sales of   $488.0
million for the first quarter last year.

The  Corporation experienced real sales growth in each of its continuing
markets.   In  the  United States, reported sales for the  quarter  were
unchanged  from  the  prior  year.  However, last  year's  sales  volume
included sales from the textile chemical business which was divested  at
the  end  of  the  second  quarter, as  well  as  sales  of  chlorinated
fluorocarbons and chlorinated solvents, which have declined as a  result
of  legislated  obsolescence.  Excluding these products,  sales  in  the
United  States grew by 5%.  Canadian sales, measured in local  currency,
increased  23%,  reflecting  a  40%  growth  in  sales  of  agricultural
products,  due in part to an acquisition completed at the  end  of  last
year.   Industrial  chemical sales in Canada  also  increased  by  6.5%.
European  sales,  when  measured  in  local  currencies,  grew  by   7%,
reflecting  signs of economic recovery in the markets served  by  Univar
Europe.

Both Canadian and European sales, when express in U.S. dollars, fail  to
reflect  this  substantial  real growth,  due  to  unfavorable  currency
exchange rates.  Compared with the first quarter last year, the Canadian
dollar  dropped  approximately  9%  against  the  U.S.  dollar  and  the
combination  of  European  currencies in the markets  served  by  Univar
Europe dropped approximately 2%.

Gross  margin percentage was 14.2% for the quarter, down from  14.4%  in
the  first quarter last year.  While European margin percentage improved
modestly, margin percentage is down in the United States, primarily as a
result  of selling the textile chemical business.  Margin percentage  is
also  down  in Canada, where the impact of record agricultural  chemical
sales which carry a lower gross margin percentage, was the major factor.

Consolidated  operating expenses, including reengineering  costs,  as  a
percent  of  sales,  were  12.8% for the first  quarter  of  this  year,
compared  with  12.7%  for  the  first  quarter  last  year.   Operating
expenses, exclusive of reengineering costs, decreased to 12.1% of sales.
The decrease occurred across all markets and is the result of continuing
success from the Corporation's cost containment programs.

During  the  third  quarter  last year,  the  Corporation  initiated  an
intensive  reengineering program which, when completed, is  expected  to
result  in significant fundamental changes in business practices in  the
operations of the Corporation.  Costs of this initiative for  the  first
quarter  totaled  $3.5 million consisting primarily of consulting  fees.
This effort will continue throughout fiscal 1995.

        
Item  2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
             AND RESULTS OF OPERATIONS, continued

The   Corporation   is  involved  in  certain  elective   and   required
environmental  programs.  The following table  shows  additions  to  and
expenditures  charged  against the Corporation's environmental  accruals
for the current and prior year comparable quarters.

                                   Three months ended
                                        May  31,
     (000's)                    1994           1993


     Beginning balance          $15.5          $15.4
  
                                           
     Expense                   
     provisions                   1.5            1.0
                                                  
     Expenditures                 -.7           -1.3
                                -----          -----
     Ending balance             $16.3          $15.1
                                =====          =====


Income taxes for the first quarter were provided at an effective rate of
51% compared with 33% for the first quarter last year.  The increase  is
due  to  a combination of non-recurring tax provision reductions in  the
prior year and a change in the mix of domestic and foreign income.   The
prior  year  quarter  included the effect  of  adopting  SFAS  No.  109,
"Accounting for Income Taxes," which resulted in a cumulative adjustment
to  reduce  deferred  taxes in the amount of $0.4 million.   During  the
current  quarter, the portion of taxable income earned in Canada,  which
is subject to higher rates compared with United States rates,  increased
by 40%.

Liquidity and Capital Resources

Working  capital at the end of the first quarter was $97.8  million,  up
from  $83.5  million at the prior year-end.  Over the same  period,  the
current  ratio  remained unchanged at 1:28:1.   The  change  in  working
capital  is  due  in  part to seasonal fluctuations in  working  capital
components related to agricultural sales.

Cash  flow  used  by operations totaled $2.4 million  for  the  quarter,
compared with cash provided by operations totaling $22.7 million for the
first  quarter  last  year.  The fluctuation for  the  quarter  reflects
changes  in components of working capital which are consistent with  the
significant increase in agricultural sales.

The  Corporation  has  domestic  and  foreign  short-term  credit  lines
totaling $85.6 million, of which $55.4 million was available at quarter-
end.   The Corporation also has access to funds up to $210 million under
a medium-term revolving credit agreement with a group of banks, of which
$140 million was available at quarter-end.  The Corporation believes its
internally generated cash, together with its access to bank lines,  will
be  adequate to fund the planned capital expenditures, investments,  and
to support its working capital requirements.

Capital Expenditures

During  the  first quarter of this fiscal year, additions  to  property,
plant,  and  equipment totaled $4.2 million, compared with $2.6  million
for  the  prior  year  quarter.   Current  quarter  additions  consisted
primarily  of  normal  replacement and upgrading  of  fixed  assets  and
construction   expenditures  for  refurbishing  warehouse   and   office
facilities.  The Corporation utilized available cash to fund the capital
expenditures.

Exercise of Dow Put Agreement

On  May 13, 1994, the Corporation exercised its unilateral right to  put
(sell) 2 million shares of common stock , priced at $l8.74 per share, to
The  Dow Chemical Company ("Dow").  Proceeds from the sale totaled $37.5
million.   Dow now holds 3.9 million shares of common stock representing
approximately  18% of the issued and outstanding shares of  Univar.   In
addition, Dow and Univar have agreed that, at any time within the  three
year period ending May 12, 1997, Univar can put to Dow, or Dow can call,
up to 101,874 shares of Series A Convertible Preferred Stock.  The price
per  share will be $93.70.  Each share of Series A Convertible Preferred
Stock  is convertible into five shares of Univar Common Stock.  Dow  has
agreed  that  it will pay to Univar $350,000 per year for  each  of  the
three  years ending May 12, 1997, in the event Univar does not elect  to
put,  or  Dow does not call, the Series A Convertible Preferred Stock  .
(See  Note  12 to the financial statements included in the Corporation's
fiscal  1994  annual  report  on Form 10-K  previously  filed  with  the
Securities and Exchange Commission.)

Univar Europe Stock Purchase Agreement

At  the  time of the organization of Univar Europe, Univar and its  then
31%  shareholder, Pakhoed Investeringen B.V. (Pakhoed), entered  into  a
Shareholder  Agreement   resulting in the formation  of  Univar  Europe,
which  was incorporated in the Netherlands in 1990.  At the time  Univar
Europe  was  capitalized, it was 51% owned by the  Corporation  and  49%
owned  by Pakhoed.  On May 18, 1994, Pakhoed gave notice to Univar  that
Pakhoed,  in  accordance  with terms of the Shareholder  Agreement,  had
elected  to  require  Univar to purchase Pakhoed's  interest  in  Univar
Europe.   The purchase is expected to close on September 1,  1994.   The
anticipated purchase price is approximately $25 million.


Part II.     OTHER INFORMATION


Item 6.    Exhibits and Reports on Form 8-K

Form  8-K, as of May 13, 1994, was filed May 17, 1994 to report (1)  the
amendment  of  two  agreements with The Dow  Chemical  Company  ("Dow"),
including  an Agreement of Purchase and Sale of Stock, and a  Standstill
Agreement, and (2) the sale by the Registrant of 2,000,000 shares of its
common stock to Dow.

Form 8-K, as of  May 18, 1994, was filed on May 19, 1994, to report  the
Registrant's  upcoming  acquisition of the minority's  49%  interest  in
Univar  Europe held by Pakhoed Investeringen B.V. as described above  in
this Form 10-Q.
        
        

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.




UNIVAR CORPORATION



Date: June 28, 1994      By: \ JAMES W. BERNARD

                         James W. Bernard
                         President and Chief Executive Officer
                         (Duly Authorized Officer)



Date: June 28, 1994      By: \ GARY E. PRUITT

                         Gary E. Pruitt
                         Vice President - Finance and Treasurer
                         (Principal Financial and Accounting Officer)





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission